Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Stille’s soft share price development over the past months to us appears more sentiment-driven than fundamental following the Q4 report.</li><li>With supply constraints now easing and the company facing easier comparables throughout 2026, should make a good cocktail for the stock.</li><li>At yesterday's close, the Stille share trades at 11x–8x 2026e–2028e EV/EBITDA.</li></ul>

Stille’s soft share price development over the past months to us appears more sentiment-driven than fundamental following the Q4 report.With supply constraints now easing and the company facing easier comparables throughout 2026, should make a good cocktail for the stock.At yesterday's close, the Stille share trades at 11x–8x 2026e–2028e EV/EBITDA.

Stille: (Q4 review): Easing headwinds and solid outlook at 11x current year EV/EBITDA